WESTMINSTER, Colo.--(BUSINESS WIRE)--Allos Therapeutics, Inc. (NASDAQ: ALTH) today announced the appointment of Charles Morris, MB ChB, MRCP, as executive vice president, chief medical officer, effective today. In his position, Dr. Morris will lead the Company’s clinical development functions, including clinical operations, medical affairs, regulatory and biometrics.
